Chronic Disease Treatment & Care

Own the businesses that repeatedly treat, monitor and manage chronic illness, rather than betting on a single drug pipeline. The basket connects established medicines with diabetes devices and ongoing care delivery, a different exposure from vaccine and biologic-development portfolios. Recent strength in several treatment franchises supports a selective allocation while the broader growth market is under pressure; reimbursement constraints and drug competition remain key risks. Launch basket (equal weight): LLY, MDT, UNH, ABBV, AMGN, ABT, DXCM, CVS Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.